In 2021, Bleyer et al.9 suggested the use of an inherited kidney disease multigene panel, including UMOD, REN, and other genes of interest, with the use of a laboratory specifically performing MUC1 targeted analysis if this multigene panel was negative. The gene discussed is REN; the disease is kidney disorder.